A detailed history of Commonwealth Equity Services, LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 22,206 shares of KPTI stock, worth $19,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,206
Previous 25,206 11.9%
Holding current value
$19,319
Previous $22,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$0.7 - $1.06 $2,100 - $3,180
-3,000 Reduced 11.9%
22,206 $18,000
Q2 2024

Jul 31, 2024

SELL
$0.87 - $1.58 $174 - $316
-200 Reduced 0.79%
25,206 $22,000
Q1 2024

Apr 29, 2024

BUY
$0.72 - $1.66 $18,292 - $42,173
25,406 New
25,406 $38,000
Q3 2022

Nov 14, 2022

SELL
$4.08 - $5.82 $11,526 - $16,441
-2,825 Reduced 21.75%
10,165 $55,000
Q2 2022

Jul 19, 2022

SELL
$4.15 - $8.37 $415 - $836
-100 Reduced 0.76%
12,990 $58,000
Q1 2022

May 04, 2022

SELL
$5.91 - $14.38 $3,546 - $8,628
-600 Reduced 4.38%
13,090 $96,000
Q4 2021

Jan 31, 2022

BUY
$5.21 - $8.61 $4,949 - $8,179
950 Added 7.46%
13,690 $88,000
Q3 2021

Oct 29, 2021

BUY
$4.45 - $10.63 $56,693 - $135,426
12,740 New
12,740 $74,000
Q1 2021

May 04, 2021

SELL
$9.85 - $17.69 $99,819 - $179,270
-10,134 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$14.15 - $17.19 $143,396 - $174,203
10,134 New
10,134 $156,000
Q1 2020

May 11, 2020

SELL
$14.38 - $27.72 $144,547 - $278,641
-10,052 Closed
0 $0
Q4 2019

Feb 05, 2020

SELL
$9.23 - $19.67 $26,628 - $56,747
-2,885 Reduced 22.3%
10,052 $192,000
Q3 2019

Oct 30, 2019

BUY
$5.66 - $11.85 $73,223 - $153,303
12,937 New
12,937 $124,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $69.4M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.